Corcept Therapeutics, PNM Resources fall; Johnson & Johnson rise, Tuesday, 1/2/2024
Stocks that traded heavily or had substantial price changes on Tuesday: Corcept Therapeutics, PNM Resources fall; Johnson & Johnson rise
Corcept (CORT) Misses on Q1 Earnings, Revises 2023 Sales Guidance
Corcept (CORT) first-quarter earnings miss estimates, while revenues beat the same. The company gives updates on its pipelines and raises revenue guidance for 2023.
Corcept Therapeutics (CORT) Lags Q1 Earnings Estimates
Corcept (CORT) delivered earnings and revenue surprises of -30% and 1.73%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More
Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.
Jazz (JAZZ) Up 0.4% Since Last Earnings Report: Can It Continue?
Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.